Evidence map›Paper›PMID 39468922›Full record

ArticleCancer biology & medicine2024

From complexity to clarity: development of CHM-FIEFP for predicting effective components in Chinese herbal formulas by using big data.

Boyu Pan, Han Zhu, Jiaqi Yang, Liangjiao Wang, Zizhen Chen, Jian Ma, Bo Zhang, Zhanyu Pan, Guoguang Ying, Shao Li and 1 more

Abstract read
In one paragraph

Article in Cancer biology & medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Boyu Pan *Department of Molecular Pharmacology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China.
Han Zhu *College of Electronic and Information Engineering, Shanghai Research Institute for Intelligent Autonomous Systems, Tongji University, Shanghai 200092, China.
Jiaqi YangDepartment of Molecular Pharmacology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China.
Liangjiao WangDepartment of Molecular Pharmacology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China.
Zizhen ChenDepartment of Molecular Pharmacology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China.
Jian MaDepartment of General Surgery, Tianjin Haihe Hospital, Tianjin 300350, China.
Bo ZhangBeijing Intelligent Medicine and Network Pharmacology Co., Ltd, Beijing 100020, China.
Zhanyu PanNational Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
Guoguang YingNational Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
Shao LiInstitute for TCM-X, MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist, Department of Automation, Tsinghua University, Beijing 100084, China.
Liren LiuDepartment of Molecular Pharmacology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China.ORCID 0000-0001-7786-7874

Funding

National Natural Science Foundation of China 81572416National Natural Science Foundation of China 82204694Tianjin Health and Family Planning Commission Program ZC20169Tianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-009A
6 · The paper itself

Abstract

objectiveThe presence of complex components in Chinese herbal medicine (CHM) hinders identification of the primary active substances and understanding of pharmacological principles. This study was aimed at developing a big-data-based, knowledge-driven

methodsNetwork pharmacology (TCMSP) and clinical (GEO) databases were searched to retrieve gene targets corresponding to the formula ingredients, herbal components, and specific disease being treated. Intersections were determined to obtain disease-specific core targets, which underwent further GO and KEGG enrichment analyses to generate non-redundant biological processes and molecular targets for the formula and each component. The ratios of the numbers of biological and molecular events associated with a component were calculated with a formula, and entropy weighting was performed to obtain a fitting score to facilitate ranking and improve identification of the key components. The established method was tested on the traditional CHM formula Danggui Sini Decoction (DSD) for gastric cancer. Finally, the effects of the predicted critical component were experimentally validated in gastric cancer cells.

resultsAn algorithm called Chinese Herb Medicine-Formula

conclusionsCHM-FIEFP is a promising

Indexed as

AlgorithmsBig DataDrugs, Chinese HerbalComputer SimulationCoumaric AcidsHumansMedicine, Chinese TraditionalNetwork PharmacologyStomach NeoplasmsCoumaric AcidsDrugs, Chinese Herbalferulic acidChinese herbal medicine (CHM)CHM-FIEFPDanggui Sini Decoctionferulic acidnetwork pharmacology

Identifiers

PMID39468922
PMCPMC11667782

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.